AKIN GUMP STRAUSS HAUER & FELD for SUN PHARMA (FORMERLY RANBAXY INC )
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 214, Preserve Access to Affordable Generics; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS New | — |
| CAITLIN SUZANNE MCCORMICK New | — |
| MATTHEW TODD TUTEN New | Rep Michael Bilirakis; 91-92, 93-95, 98-01 |
| ANURAG VARMA New | — |
Pharmacy PHA
S.27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 214, Preserve Access to Affordable Generics; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS New | — |
| CAITLIN SUZANNE MCCORMICK New | — |
| MATTHEW TODD TUTEN New | Rep Michael Bilirakis; 91-92, 93-95, 98-01 |
| ANURAG VARMA New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| RANBAXY LABS LTD | India | India | 100.0% | $90,000 |
Affiliated organisations
| Organisation | Location |
|---|---|
| RANBAXY LABS LTD | Gurgaon, Haryana, IN |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.